CN102716290B - Traditional Chinese medicine for treating bronchial asthma - Google Patents

Traditional Chinese medicine for treating bronchial asthma Download PDF

Info

Publication number
CN102716290B
CN102716290B CN 201210231814 CN201210231814A CN102716290B CN 102716290 B CN102716290 B CN 102716290B CN 201210231814 CN201210231814 CN 201210231814 CN 201210231814 A CN201210231814 A CN 201210231814A CN 102716290 B CN102716290 B CN 102716290B
Authority
CN
China
Prior art keywords
parts
weight
chinese medicine
grams
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201210231814
Other languages
Chinese (zh)
Other versions
CN102716290A (en
Inventor
许瑞琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bian Yongxing
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210231814 priority Critical patent/CN102716290B/en
Publication of CN102716290A publication Critical patent/CN102716290A/en
Application granted granted Critical
Publication of CN102716290B publication Critical patent/CN102716290B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine for treating bronchial asthma. The traditional Chinese medicine is prepared by the following medicine components by part of weight: 5-15 parts of ephedra, 5-15 parts of almond, 10-20 parts of pericarpium citri reticulatae, 5-15 parts of pinellia ternate, 10-20 parts of cynanchum glaucescens, 10-20 parts of radix peucedani, 10-20 parts of folium eriobotryae and 5-10 parts of liquorice. The traditional Chinese medicine has the effect of freeing lung and relieving asthma and expelling phlegm and arresting coughing.

Description

A kind of Chinese medicine that is used for the treatment of bronchial asthma
Technical field:
The invention belongs to the field of Chinese medicines, particularly a kind of Chinese medicine for the treatment of bronchial asthma.
Background technology:
Bronchial asthma (be called for short: asthma) be a kind of commonly encountered diseases, frequently-occurring disease.At present, global asthmatic patient medicine 300,000,000 people, Chinese asthmatic patient medicine 3,000 ten thousand.Asthma is to influence the able-bodied important diseases of people.Treat untimelyly, lack of standardization, asthma may be fatal, and the risk factor of asthma morbidity comprises host factor (inherited genetic factors) and two aspects of environmental factors.Inherited genetic factors can embody on one's body a lot of patients, in the middle of most patients' relatives (have relationship by blood, nearly three generations people), asthma (recurrent cough, pant) or other anaphylactic diseases (allergic rhinitis, atopic dermatitis) medical history can have been traced back to.Most of asthmatic patients belong to allergic constitution, itself may be with allergic rhinitis and atopic dermatitis, perhaps to the allergen (acarid, pollen, house pet, mycete etc.) of common air-borne transmission, some food (nut, milk, Semen arachidis hypogaeae, seafood etc.), drug allergy etc.Present Therapeutic Method mainly is by Drug therapy, and the medicine for the treatment of asthma can be divided into control medicine and cushion, but can only accomplish control and alleviation for patient, can not tackle the problem at its root.
Summary of the invention:
Comprehensively above-mentioned, in order to overcome the deficiency of prior art problem, it is simple that the present invention has developed a kind of configuration, the Chinese medicine for the treatment of bronchial asthma evident in efficacy.
The object of the present invention is achieved like this: a kind of Chinese medicine that is used for the treatment of bronchial asthma comprises that following parts of medicines by weight is prepared from: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 5~15 parts by weight, 5~15 parts by weight, the Pericarpium Citri Reticulatae of 10~20 parts by weight, 5~15 parts by weight, the Rhizoma Cynanchi Stauntonii of 10~20 parts by weight, 10~20 parts by weight, the Folium Eriobotryae of 10~20 parts by weight, the Radix Glycyrrhizae of 5~10 parts by weight.
Technical scheme of the present invention can be achieved in that
A kind of Chinese medicine that is used for the treatment of bronchial asthma comprises that following parts of medicines by weight is prepared from: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 10 parts by weight, 10 parts by weight, the Pericarpium Citri Reticulatae of 15 parts by weight, 10 parts by weight, the Rhizoma Cynanchi Stauntonii of 15 parts by weight, 15 parts by weight, the Folium Eriobotryae of 15 parts by weight, the Radix Glycyrrhizae of 7 parts by weight.
The present invention mixes each raw material, is ground into fine powder, directly take, and every day three times, each 2-3 gram, warm water takes.
The course for the treatment of: 30 days is a course for the treatment of, need take the 3-5 course for the treatment of.
Pharmacology of the present invention and document are according to being:
Herba Ephedrae: hot, little hardship, temperature; Effect: diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema.
Semen Armeniacae Amarum: hardship, temperature, poisonous; Effect: expelling phlegm for arresting cough, relieving asthma intestine moistening.
Pericarpium Citri Reticulatae: hot, bitter, temperature; Effect: regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.
The Rhizoma Pinelliae: hot, warm, poisonous; Effect: drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.
Rhizoma Cynanchi Stauntonii: hot, bitter, tepor; Effect: sending down the abnormal ascending QI, expectorant, cough-relieving.
Radix Peucedani: bitter, hot, be slightly cold; Effect: the wind heat clearing away of loosing, lowering the adverse-rising QI to resolve phlegm.
Folium Eriobotryae: hardship is slightly cold; Effect: clearing away lung-heat to relieve cough, stopping nausea and vomiting by lowering the adverse flow of QI.
Radix Glycyrrhizae: sweet, flat; Effect: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
Epheday intermedia depressed lung-energy dispersing of the present invention, the Semen Armeniacae Amarum expelling phlegm for arresting cough helps Herba Ephedrae conditioning lung qi, Pericarpium Citri Reticulatae, Rhizoma Pinelliae drying dampness to eliminate phlegm, Rhizoma Cynanchi Stauntonii, Radix Peucedani, Folium Eriobotryae lowering the adverse-rising QI to resolve phlegm, clearing and antitussive, Radix Glycyrrhizae expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription, all medicines have share the merit of depressed lung-energy dispersing, expelling phlegm for arresting cough.
Beneficial effect of the present invention:
The present invention is formulated with pure Chinese medicine, and scientific formulation is reasonable, and configuration is simple, has no side effect, and curative effect is short, and instant effect has the effect of depressed lung-energy dispersing, expelling phlegm for arresting cough.
The specific embodiment:
Be described in further details below in conjunction with the present invention of embodiment:
Embodiment 1: a kind of Chinese medicine that is used for the treatment of bronchial asthma comprises that the medication preparation of following weight grams forms: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 10 grams, 10 grams, the Pericarpium Citri Reticulatae of 15 grams, 10 grams, the Rhizoma Cynanchi Stauntonii of 15 grams, 15 grams, the Folium Eriobotryae of 15 grams, the Radix Glycyrrhizae of 7 grams.
Embodiment 2: a kind of Chinese medicine that is used for the treatment of bronchial asthma comprises that the medication preparation of following weight grams forms: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 15 grams, 15 grams, the Pericarpium Citri Reticulatae of 20 grams, 15 grams, the Rhizoma Cynanchi Stauntonii of 20 grams, 20 grams, the Folium Eriobotryae of 20 grams, the Radix Glycyrrhizae of 10 grams.
Embodiment 3: a kind of Chinese medicine that is used for the treatment of bronchial asthma comprises that the medication preparation of following weight grams forms: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 5 grams, 5 grams, the Pericarpium Citri Reticulatae of 10 grams, 5 grams, the Rhizoma Cynanchi Stauntonii of 10 grams, 10 grams, the Folium Eriobotryae of 10 grams, the Radix Glycyrrhizae of 5 grams.
Embodiment 4: a kind of Chinese medicine that is used for the treatment of bronchial asthma comprises that the medication preparation of following weight grams forms: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 12 grams, 8 grams, the Pericarpium Citri Reticulatae of 16 grams, 8 grams, the Rhizoma Cynanchi Stauntonii of 12 grams, 11 grams, the Folium Eriobotryae of 13 grams, the Radix Glycyrrhizae of 6 grams.
Chinese medicine among the embodiment 1-4 mixes each raw material in the preparation, is ground into fine powder, directly takes, and every day three times, each 1-2 gram takes with warm water.
The present invention is not limited to above-mentioned preferred forms, and other any and this bright identical or akin products that anyone draws under enlightenment of the present invention all drop within protection scope of the present invention.
The result of clinical observation of the present invention is as follows:
Criterion of therapeutical effect:
Cure: cough, expectorant, breathe heavily, cardinal symptom basic controlling such as inflammation, stable disease, no recidivist.
Effectively: the state of an illness is relatively stable, and attack times and degree obviously alleviate, ordinary circumstance (comprising diet, sleep, the muscle power etc.) person of having clear improvement.
Invalid: through a period of time treatment, attack times, degree and ordinary circumstance do not have any improvement.
Curative effect of medication is observed situation:
Drug therapy 174 people of the present invention, healing person 146 people, responder 16 people, nonresponder 12 people, effective percentage 93%.
Model case:
Xu certain: the man, 42 years old, Henan flat-top recluse, asthma was shown effect 3 years repeatedly, cough aggravation recently, the frothy sputum shape, by the here Drug therapy, one and a half months takes effect, recovery from illness in three months.
Lee: the woman, 51 years old, people from Ye County, Henan suffered from asthma 2 years, and by the here Drug therapy, one and a half months takes effect, recovery from illness in three months.
For certain: the man, 28 years old, table mountain Weidong District people suffered from asthma 5 years, took Drug therapy for a long time but effect is all not obvious, by the here Drug therapy, two months take effect, recovery from illness in five months.

Claims (2)

1. a Chinese medicine that is used for the treatment of bronchial asthma is characterized in that: be prepared from by following parts of medicines by weight: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 5~15 parts by weight, 5~15 parts by weight, the Pericarpium Citri Reticulatae of 10~20 parts by weight, 5~15 parts by weight, the Rhizoma Cynanchi Stauntonii of 10~20 parts by weight, 10~20 parts by weight, the Folium Eriobotryae of 10~20 parts by weight, the Radix Glycyrrhizae of 5~10 parts by weight.
2. the Chinese medicine that is used for the treatment of bronchial asthma according to claim 1 is characterized in that: be prepared from by following parts of medicines by weight: the Radix Peucedani of the Rhizoma Pinelliae of the Semen Armeniacae Amarum of the Herba Ephedrae of 10 parts by weight, 10 parts by weight, the Pericarpium Citri Reticulatae of 15 parts by weight, 10 parts by weight, the Rhizoma Cynanchi Stauntonii of 15 parts by weight, 15 parts by weight, the Folium Eriobotryae of 15 parts by weight, the Radix Glycyrrhizae of 7 parts by weight.
CN 201210231814 2012-07-06 2012-07-06 Traditional Chinese medicine for treating bronchial asthma Expired - Fee Related CN102716290B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210231814 CN102716290B (en) 2012-07-06 2012-07-06 Traditional Chinese medicine for treating bronchial asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210231814 CN102716290B (en) 2012-07-06 2012-07-06 Traditional Chinese medicine for treating bronchial asthma

Publications (2)

Publication Number Publication Date
CN102716290A CN102716290A (en) 2012-10-10
CN102716290B true CN102716290B (en) 2013-08-28

Family

ID=46942244

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210231814 Expired - Fee Related CN102716290B (en) 2012-07-06 2012-07-06 Traditional Chinese medicine for treating bronchial asthma

Country Status (1)

Country Link
CN (1) CN102716290B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1899563A (en) * 2005-07-18 2007-01-24 雷广前 Medicinal wine for treating trachitis and pulmonary emphysema dyspneic cough

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1899563A (en) * 2005-07-18 2007-01-24 雷广前 Medicinal wine for treating trachitis and pulmonary emphysema dyspneic cough

Also Published As

Publication number Publication date
CN102716290A (en) 2012-10-10

Similar Documents

Publication Publication Date Title
CN104352587A (en) Ointment for treating rhinitis
CN104857080A (en) Nose drop for treating nasosinusitis
CN101983675A (en) Traditional Chinese medicine composition for treating asthma and preparation method thereof
CN1433792A (en) Traditional Chinese medicine for treating child pneumonia
CN103550643A (en) Traditional Chinese medicine for treating tuberculosis
CN103142733B (en) Chinese medicine composition for treating upper respiratory infection
CN104288477A (en) Traditional Chinese medicine preparation curing infantile asthma
CN102716290B (en) Traditional Chinese medicine for treating bronchial asthma
CN103405602A (en) Medicament for treating asthma
CN103463517B (en) Medicament for treating asthma
CN104998080A (en) Traditional Chinese medicine composition for curing cough variant asthma
CN103977111B (en) A kind of Chinese medicine for the treatment of chronic hepatitis
CN103861071A (en) Externally applied traditional Chinese medicament for treating scapulohumeral periarthritis
CN102755609B (en) Plaster for treating bronchitis
CN103446485B (en) Traditional Chinese medicine external application agent for treating juvenile bronchial asthma
CN103536673B (en) Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof
CN102727639A (en) External-use medicine for treating venereal disease
CN102727733B (en) Traditional Chinese medicine used for treating chronic bronchitis
CN101664466A (en) Traditional Chinese herbal composition for treating pyretic pulmonary disease of animals and preparation method thereof
CN101238855A (en) Chinese medicinal composition for preventing and controlling respiratory disease of birds and preparation thereof
CN106237208A (en) Chinese medicine pill for the treatment of chronic rhinitis and preparation method thereof
CN105362548A (en) Traditional Chinese medicine for treating allergic asthma
CN104161835A (en) Traditional Chinese medicine for treating phlegm-heat-type cough
CN101829286B (en) Lung moistening and cough relieving pills
CN102824522B (en) Medicine for treating infectious pneumonia and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BIAN YONGXING

Free format text: FORMER OWNER: XU RUIQIN

Effective date: 20140618

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 467000 PINGDINGSHAN, HENAN PROVINCE TO: 201600 SONGJIANG, SHANGHAI

TR01 Transfer of patent right

Effective date of registration: 20140618

Address after: 201600 Shanghai, Songjiang District Pine Road, Lane 1399, room 143, No. 807

Patentee after: Bian Yongxing

Address before: 467000 East worker Town, Weidong District, Henan, Pingdingshan

Patentee before: Xu Ruiqin

CP02 Change in the address of a patent holder
CP02 Change in the address of a patent holder

Address after: 225500 Taizhou, Jiangyan, Yu Zhang Town, Yu Shu Road, No. 1

Patentee after: Bian Yongxing

Address before: 201600 Shanghai, Songjiang District Pine Road, Lane 1399, room 143, No. 807

Patentee before: Bian Yongxing

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130828

Termination date: 20180706

CF01 Termination of patent right due to non-payment of annual fee